AZN and AZN:LN Related Headlines
Go Back- AstraZeneca (AZN:LN) (AZN) PT Raised to GBP170 at Berenberg
- AstraZeneca (AZN:LN) (AZN) PT Raised to GBP160 at Berenberg
- Citi Starts AstraZeneca (AZN:LN) (AZN) at Buy
- AstraZeneca (AZN:LN) (AZN) PT Raised to GBP163 at UBS
- AstraZeneca (AZN:LN) (AZN) PT Raised to GBP110 at Deutsche Bank
- Guggenheim Reiterates Buy Rating on AstraZeneca (AZN:LN) (AZN)
- AstraZeneca (AZN:LN) (AZN) PT Raised to GBP165 at Barclays
- AstraZeneca (AZN:LN) (AZN) PT Raised to GBP155 at Morgan Stanley
- UBS Reiterates Buy Rating on AstraZeneca (AZN:LN) (AZN)
- Jefferies Upgrades AstraZeneca (AZN:LN) (AZN) to Buy
- AstraZeneca (AZN:LN) (AZN) PT Raised to GBP145 at Berenberg
- Deutsche Bank Downgrades AstraZeneca (AZN:LN) (AZN) to Sell
- AstraZeneca (AZN:LN) (AZN) PT Raised to GBP150.13 at Goldman Sachs
- Goldman Sachs Reiterates Conviction Buy Rating on AstraZeneca (AZN:LN) (AZN)
- Deutsche Bank Reiterates Hold Rating on AsztraZeneca PLC (AZN:LN) (AZN)

